Stay updated on Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.
Latest updates to the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference1%
- Check53 days agoChange DetectedNew registry identifiers were added for CTIS (EU) on November 18 and 19, 2024, while numerous links and resources related to ovarian cancer and clinical trials were removed.SummaryDifference3%
- Check60 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new resources added related to ovarian cancer, including links to clinical trials, treatment information, and relevant studies.SummaryDifference3%
- Check75 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.0%
Stay in the know with updates to Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.